Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer

NCT02633098 is registered in ClinicalTrials.gov with St George's, University of London as lead sponsor.

NCT NCT02633098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02633098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Randomised, Double Blind, Placebo Controlled Trial of Neoadjuvant Artesunate in Stage II/III Colorectal Cancer
Lead sponsor
St George's, University of London
Phase
Phase 2
Overall status
Unknown status
Start date
April 26, 2017
Completion date
October 31, 2025
Enrollment
200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bowel cancer, colorectal cancer